导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 23.65% | 957/2255 |
| 近一周 | -1.10% | 1500/2318 |
| 近一月 | 0.64% | 563/2314 |
| 近一季 | 2.45% | 622/2310 |
| 近半年 | 15.38% | 1168/2290 |
| 近一年 | 23.19% | 868/2246 |
| 近两年 | 29.02% | 923/2172 |
| 近三年 | -1.59% | 1576/2050 |
| 成立以来 | 241.73% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2025 | - - |
-1.21% 1917/2331 |
10.20% 170/2353 |
16.71% 1224/2347 |
- - |
| 2024 | 4.12% 1131/2336 |
-13.00% 2218/2322 |
-0.85% 1073/2326 |
14.07% 394/2322 |
5.82% 243/2336 |
| 2023 | -23.38% 1996/2330 |
-6.31% 2172/2290 |
-4.32% 1523/2303 |
-12.04% 1811/2318 |
-2.82% 1073/2330 |
| 2022 | -18.31% 1207/2299 |
-15.33% 1270/2227 |
5.35% 1010/2269 |
-8.24% 1082/2294 |
-0.20% 902/2300 |
| 2021 | 16.35% 462/2205 |
-1.86% 1164/2009 |
7.14% 918/2060 |
6.54% 285/2103 |
3.86% 709/2208 |
| 2020 | 43.35% 856/2086 |
4.93% 242/1861 |
8.88% 1189/1950 |
11.05% 717/2010 |
12.98% 691/2031 |
| 2019 | 49.93% 332/1974 |
16.01% 1608/3054 |
1.87% 523/3201 |
10.10% 268/1861 |
15.22% 83/1886 |
| 2018 | -16.20% 882/1913 |
- - |
- - |
- - |
-3.15% 1018/2977 |
| 2017 | 30.78% 90/1885 |
- - |
- - |
- - |
- - |
| 2016 | -10.35% 598/1510 |
- - |
- - |
- - |
- - |
| 2015 | 38.21% 151/849 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 创金合信全球医药生物股票发起(QDII)C | 1.8048 | 37.74% |
| 泰信现代服务业混合 | 2.0450 | 32.88% |
| 易方达标普生物科技人民币A | 1.7298 | 28.02% |
| 永赢高端装备智选混合发起A | 1.1625 | 27.65% |
| 永赢高端装备智选混合发起C | 1.1467 | 27.52% |
| 金信稳健策略混合A | 2.2741 | 23.08% |
| 金信精选成长混合A | 1.6584 | 22.49% |
| 金信精选成长混合C | 1.6361 | 22.31% |
| 东方人工智能主题混合C | 1.5534 | 22.12% |
| 金信行业优选混合发起式A | 2.7474 | 21.61% |
| 富国宏观策略灵活配置混合A VS. () |